ESPR - Esperion Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ESPR (1434868)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

18 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-11-03
ESPRBiotech Target N V10%P - Purchase$25.31+200,0003,947,964+5%+$5,062,120
2020-03-11
ESPRMayleben Timothy MPres, CEOP - Purchase$43.00+2,500111,998+2%+$107,500
2020-02-28
ESPRMayleben Timothy MPres, CEOP - Purchase$49.00+5,000109,498+5%+$245,000
2020-01-23
ESPRBiotech Target N V10%P - Purchase$52.12+20,0003,747,964+1%+$1,042,398
2019-11-06
ESPRMayleben Timothy MPres, CEOP - Purchase$36.98+5,00083,663+6%+$184,900
2019-11-06
ESPRBiotech Target N V10%P - Purchase$37.30+75,0003,727,964+2%+$2,797,560
M
2019-09-04
ESPRMayleben Timothy MPres, CEOP - Purchase$34.55+7,50078,663+11%+$259,107
2019-09-04
ESPRBiotech Target N V10%P - Purchase$33.78+80,0003,652,964+2%+$2,702,208
2019-08-01
ESPRMayleben Timothy MPres, CEOP - Purchase$39.56+5,00071,163+8%+$197,800
2019-07-23
ESPRBiotech Target N V10%P - Purchase$42.65+50,0003,572,964+1%+$2,132,565
2019-06-28
ESPRMayleben Timothy MPres, CEOP - Purchase$46.00+5,00066,163+8%+$230,000
2019-04-03
ESPRBartram RichardCFOS - Sale$42.88-8,00011,092-42%-$343,045
2019-03-29
ESPRMayleben Timothy MPres, CEOP - Purchase$40.00+5,00061,163+9%+$200,000
2019-03-20
ESPRMayleben Timothy MPres, CEOP - Purchase$43.48+5,00056,163+10%+$217,400
2019-03-19
ESPRVitullo NicoleDirS - Sale$44.73-15,3298,319-65%-$685,596
2019-03-14
ESPRBiotech Target N V10%P - Purchase$49.89+50,0003,522,964+1%+$2,494,355
2019-03-14
ESPRMayleben Timothy MPres, CEOP - Purchase$48.73+5,00051,163+11%+$243,650
2019-03-12
ESPRNewton Roger SDirS - Sale$50.06-25,000548,726-4%-$1,251,500

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top